CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins
T-cell bispecific antibodies (TCBs) are a novel class of engineered immunoglobulins that unite monovalent binding to the T-cell receptor (TCR) CD3e chain and bivalent binding to tumor-associated antigens in order to recruit and activate T-cells for tumor cell killing. In vivo, T-cell activation is u...
Saved in:
Main Authors: | Christian Jost (Author), Diana Darowski (Author), John Challier (Author), Vesna Pulko (Author), Lydia J Hanisch (Author), Wei Xu (Author), Ekkehard Mössner (Author), Alexander Bujotzek (Author), Stefan Klostermann (Author), Pablo Umana (Author), Roland E. Kontermann (Author), Christian Klein (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of TCR Vβ11-2-Dβ1-Jβ1-1 T cell clone specific for WT1 peptides using high-throughput TCRβ gene sequencing
by: Yikai Zhang, et al.
Published: (2019) -
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
by: Sachiko Okamoto, et al.
Published: (2012) -
TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
by: Yuntao Wang, et al.
Published: (2022) -
Circulating TCR γδ Cells in the Patients with Systemic Lupus Erythematosus
by: Ewa Robak, et al.
Published: (1999) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023)